e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Pleural and lower respiratory tract infections and bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pharmacokinetics and pharmacoynamics of clarithromycin in the empyema pleural fluid
I. E. Liapakis, M. S. Pitiakoudis, A. J. Karayiannakis, S. E. Constantinos, T. Thomas, K. Pantelis, D. E. Bouros (Alexandroupolis, Athens, Greece)
Source:
Annual Congress 2004 - Pleural and lower respiratory tract infections and bronchiectasis
Session:
Pleural and lower respiratory tract infections and bronchiectasis
Session type:
Thematic Poster Session
Number:
3879
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. E. Liapakis, M. S. Pitiakoudis, A. J. Karayiannakis, S. E. Constantinos, T. Thomas, K. Pantelis, D. E. Bouros (Alexandroupolis, Athens, Greece). Pharmacokinetics and pharmacoynamics of clarithromycin in the empyema pleural fluid. Eur Respir J 2004; 24: Suppl. 48, 3879
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Penetration of azithromycin in experimental pleural empyema model fluid
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Penetration of linezolide in experimental pleural empyema model fluid
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007
Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema
Source: Annual Congress 2008 - Pleural effusion
Year: 2008
Intrapleural tenectaplase therapy in treatment of loculated parapneumonic pleural effusions and empyema
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Intrapleural streptokinase in the management of loculated pleural fluids of various aetiologies
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Long-term use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012
Medical thoracoscopic pleural lavage by sodium bicarbonate in complicated parapneumonic effusion and empyema
Source: International Congress 2017 – Pleural interventions and transthoracic ultrasound (TUS)
Year: 2017
Pleurodesis with erythromycin in large and recurrent malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 72s
Year: 2005
Malignant pleural effusion: treatment of the fluid and intrapleural therapy
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
Parapneumonic effusion and empyema
Source: Respipedia Article
Year: 2017
Pleural tuberculosis and empyema
Source: Annual Congress 2003 - PG15 - Pleural diseases
Year: 2003
Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural effusion
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009
Pleural infection and empyema
Source: Annual Congress 2012 - PG16 ERS/ACCP joint course on diagnostic and management strategies for pleural disorders
Year: 2012
Efficacy of rapid pleurodesis in malignat pleural effusions
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010
Treatment of parapneumonic pleural effusion and empyema: conservative view
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199
Year: 2004
Respiratory functional status after intrapleural t-PA administration for complicated parapneumonic effusions
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Mortality and bacteriology in pleural empyema
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
The effect of intrapleural fibrinolytic therapy in the drainage of loculated haemorrhagic effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001
Early effective drainage in the treatment of loculated tuberculous pleurisy
Source: Eur Respir J 2008; 31: 1261-1267
Year: 2008
Efficacy of doxycycline with small-bore catheters in patients with malignant pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 772s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept